Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.

Erika MartinelliDavide CiardielloGiulia MartiniStefania NapolitanoSara Del TufoLuca D'AmbrosioMarco De ChiaraVincenzo FamigliettiValeria NaccaClaudia CardoneAntonio AvalloneChiara CremoliniFilippo PietrantonioEvaristo MaielloVincenza GranataTeresa TroianiSalvatore CappabiancaFortunato CiardielloValerio NardoneAlfonso Reginelli

Published in: Clinical drug investigation (2024)

by radiomic analysis correlates with improved outcomes in patients with LM receiving cetuximab rechallenge plus avelumab therapy. Larger prospective studies are needed to validate and confirm these findings.

Keyphrases

metastatic colorectal cancer
squamous cell carcinoma
adipose tissue
combination therapy
insulin resistance
weight loss
replacement therapy